Simcyp wins enterprise award
A Sheffield University spin-out that has developed software to simulate how the body deals with new drugs has won a Queen’s Award for Enterprise.
Simcyp, which was spun-out of the university’s School of Medicine and Biomedical Sciences in 2001, has developed modelling and simulation software that enables pharmaceutical scientists to analyse how a drug is absorbed, distributed, metabolised and excreted in virtual populations of patients, prior to clinical trials in humans.
By including extensive information on demographics, genetics, environmental factors and disease state, complex ‘real-life’ scenarios can be easily investigated including the likelihood and effects of drug-drug interactions.
The company’s flagship product - the Simcyp Population-based ADME Simulator - is used by the world’s top pharmaceutical companies including Pfizer, Johnson & Johnson and AstraZeneca.
The Simcyp simulator helps such pharmaceutical companies to take advantage of routinely generated data to prioritise promising drug candidates earlier in development.
Simulations can also optimise the design of human trials, minimising unnecessary drug exposure to human volunteers and animals. This has significant cost and time-saving benefits in the development of new medicinal products.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Construction industry lags in tech adoption
Are these the best people to ask "Insights from 2,000 Industry Leaders"? - what would their customers views be like (perhaps more...